Science Explorer Back to mapMap
Discussion
Researcher · Shikoku Cancer Center · Japan

Toshiyuki Kozuki

Toshiyuki Kozuki publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.

ORCID 0000-0001-8432-8975 OpenAlex
World rank
#672,190
of 7,710,434 ranked researchers
Rank in Japan
#7,676
of 383,136
Works
245
Citations
6.6k
Citations per work
26.8
h-index
34
i10-index 84Top 6.7% in Pulmonary and Respiratory Medicine
Toshiyuki Kozuki

What does Toshiyuki Kozuki research?

Toshiyuki Kozuki's work is mostly in Medicine (83%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 204 works · 83.3% of their workMedicine: 204 works · 83.3% of their workPulmonary and Respiratory Medicine: 104 works · 42.5% of their workOncology: 80 works · 32.8% of their workRadiology, Nuclear Medicine and Imaging: 8 works · 3.4% of their workSurgery: 7 works · 2.9% of their workNeurology: 4 works · 1.7% of their workEverything else: 27 works · 11.0% of their workLife Sciences: 14 works · 5.7% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 5.7% of their workMolecular Biology: 14 works · 5.7% of their workTHEIR WORKToshiyuki Kozuki245works
Life Sciences6%Health Sciences83%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine20483.3%
  2. Everything else2711.0%
    1. Biochemistry, Genetics and Molecular Biology145.7%
  1. 1Pulmonary and Respiratory Medicine42% of their works
  2. 2Oncology33% of their works
  3. 3Molecular Biology6% of their works
  4. 4Radiology, Nuclear Medicine and Imaging3% of their works
  5. 5Surgery3% of their works
  6. 6Neurology2% of their works

Research topics

Which keywords describe Toshiyuki Kozuki's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, CT Screening, Lung Cancer and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy2075 topics
  2. Clinical Trials1912 topics
  3. Targeted Therapy1912 topics
  4. ALK Inhibitors1231 topic
  5. EGFR Mutations1231 topic
  6. CT Screening761 topic
  7. Lung Cancer761 topic
  8. Genomic Profiles681 topic
  9. Small-Cell Lung Cancer681 topic
  10. Immune Checkpoint Blockade391 topic
  11. PD-1 and PD-L1391 topic
  12. Cetuximab321 topic
  13. KRAS Mutations321 topic
  14. DNA191 topic
  15. Topoisomerases191 topic
  16. Breast Cancer121 topic
  17. HER2121 topic
  18. Fibrosis111 topic
  19. Idiopathic Pulmonary Fibrosis111 topic

Where does Toshiyuki Kozuki work?

Toshiyuki Kozuki's main affiliation in the publication record is Shikoku Cancer Center, Japan.

How many publications and citations does Toshiyuki Kozuki have?

OpenAlex counts 245 works and 6,561 citations for Toshiyuki Kozuki, an h-index of 34, ranking #672,190 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Toshiyuki Kozuki

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Toshiyuki Kozuki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.